Mast Therapeutics, Inc. (MSTX)

[PETERDENIEL2003]

ANX- 530 Exelbine , a novel emulsion formulation of the chemotherapy drug vinorelbine (Navelbine®);

Exelbine or Improved Vinorelbine would definately get FDA Approval as Vinorelbine received approval by the United States Food and Drug Administration (FDA) in December 1994 sponsored by Burroughs Wellcome Company

Drug vinorelbine was invented by the pharmacist Pierre Potier and his team from the CNRS in France in the 1980s and was licensed to the oncology department of the Pierre Fabre Group. The drug was approved in France in 1989 under the brand name Navelbine for the treatment of non-small cell lung cancer. It gained approval to treat metastatic breast cancer in 1991.



In most European countries, vinorelbine is approved to treat non-small cell lung cancer and breast cancer.